File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.5966/sctm.2016-0109
- Scopus: eid_2-s2.0-85017367988
- PMID: 28170199
- WOS: WOS:000398194800017
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Concise Review: Cell Surface N-Linked Glycoproteins as Potential Stem Cell Markers and Drug Targets
Title | Concise Review: Cell Surface N-Linked Glycoproteins as Potential Stem Cell Markers and Drug Targets |
---|---|
Authors | |
Keywords | Stem cell Pluripotent stem cells Drug target Technology Proteomics Immunophenotyping |
Issue Date | 2017 |
Publisher | AlphaMed Press, Inc. The Journal's web site is located at http://stemcellsjournals.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2157-6580/ |
Citation | Stem Cells Translational Medicine, 2017, v. 6 n. 1, p. 131-138 How to Cite? |
Abstract | Stem cells and their derivatives hold great promise to advance regenerative medicine. Critical to the progression of this field is the identification and utilization of antibody‐accessible cell‐surface proteins for immunophenotyping and cell sorting—techniques essential for assessment and isolation of defined cell populations with known functional and therapeutic properties. Beyond their utility for cell identification and selection, cell‐surface proteins are also major targets for pharmacological intervention. Although comprehensive cell‐surface protein maps are highly valuable, they have been difficult to define until recently. In this review, we discuss the application of a contemporary targeted chemoproteomic‐based technique for defining the cell‐surface proteomes of stem and progenitor cells. In applying this approach to pluripotent stem cells (PSCs), these studies have improved the biological understanding of these cells, led to the enhanced use and development of antibodies suitable for immunophenotyping and sorting, and contributed to the repurposing of existing drugs without the need for high‐throughput screening. The utility of this latter approach was first demonstrated with human PSCs (hPSCs) through the identification of small molecules that are selectively toxic to hPSCs and have the potential for eliminating confounding and tumorigenic cells in hPSC‐derived progeny destined for research and transplantation. Overall, the cutting‐edge technologies reviewed here will accelerate the development of novel cell‐surface protein targets for immunophenotyping, new reagents to improve the isolation of therapeutically qualified cells, and pharmacological studies to advance the treatment of intractable diseases amenable to cell‐replacement therapies. |
Persistent Identifier | http://hdl.handle.net/10722/234849 |
ISSN | 2023 Impact Factor: 5.4 2023 SCImago Journal Rankings: 1.401 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Boheler, KR | - |
dc.contributor.author | Gundry, R | - |
dc.date.accessioned | 2016-10-14T13:49:39Z | - |
dc.date.available | 2016-10-14T13:49:39Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Stem Cells Translational Medicine, 2017, v. 6 n. 1, p. 131-138 | - |
dc.identifier.issn | 2157-6564 | - |
dc.identifier.uri | http://hdl.handle.net/10722/234849 | - |
dc.description.abstract | Stem cells and their derivatives hold great promise to advance regenerative medicine. Critical to the progression of this field is the identification and utilization of antibody‐accessible cell‐surface proteins for immunophenotyping and cell sorting—techniques essential for assessment and isolation of defined cell populations with known functional and therapeutic properties. Beyond their utility for cell identification and selection, cell‐surface proteins are also major targets for pharmacological intervention. Although comprehensive cell‐surface protein maps are highly valuable, they have been difficult to define until recently. In this review, we discuss the application of a contemporary targeted chemoproteomic‐based technique for defining the cell‐surface proteomes of stem and progenitor cells. In applying this approach to pluripotent stem cells (PSCs), these studies have improved the biological understanding of these cells, led to the enhanced use and development of antibodies suitable for immunophenotyping and sorting, and contributed to the repurposing of existing drugs without the need for high‐throughput screening. The utility of this latter approach was first demonstrated with human PSCs (hPSCs) through the identification of small molecules that are selectively toxic to hPSCs and have the potential for eliminating confounding and tumorigenic cells in hPSC‐derived progeny destined for research and transplantation. Overall, the cutting‐edge technologies reviewed here will accelerate the development of novel cell‐surface protein targets for immunophenotyping, new reagents to improve the isolation of therapeutically qualified cells, and pharmacological studies to advance the treatment of intractable diseases amenable to cell‐replacement therapies. | - |
dc.language | eng | - |
dc.publisher | AlphaMed Press, Inc. The Journal's web site is located at http://stemcellsjournals.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2157-6580/ | - |
dc.relation.ispartof | Stem Cells Translational Medicine | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Stem cell | - |
dc.subject | Pluripotent stem cells | - |
dc.subject | Drug target | - |
dc.subject | Technology | - |
dc.subject | Proteomics | - |
dc.subject | Immunophenotyping | - |
dc.title | Concise Review: Cell Surface N-Linked Glycoproteins as Potential Stem Cell Markers and Drug Targets | - |
dc.type | Article | - |
dc.identifier.email | Boheler, KR: bohelerk@hku.hk | - |
dc.identifier.authority | Boheler, KR=rp01884 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.5966/sctm.2016-0109 | - |
dc.identifier.pmid | 28170199 | - |
dc.identifier.pmcid | PMC5442750 | - |
dc.identifier.scopus | eid_2-s2.0-85017367988 | - |
dc.identifier.hkuros | 270352 | - |
dc.identifier.hkuros | 268979 | - |
dc.identifier.volume | 6 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 131 | - |
dc.identifier.epage | 138 | - |
dc.identifier.isi | WOS:000398194800017 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 2157-6564 | - |